BCPA: Under the new regime the quality of medications will be impacted

By
Updated: November 14, 2017

The Belize Community Pharmacist Association, BCPA, is calling on the Ministry of Health and by extension the Government of Belize to consider the impacts which will be caused by the implementation of a new regime for the pharmaceutical industry. The new policies and procedures are expected to be effected this month with the signing of a Statutory Instrument of the Food and Drugs Regulations Act. The BCPA says that under the new regime, the quality and reliability of medications sold to the public will be impacted. In a statement, the BCPA explained that quote, “With the new requirements set out in the Food and Drug Regulations for 2017, pharmacists will no longer be able to satisfy the needs of the community with drugs of quality standard that the public has become accustomed to getting from private pharmacies. We are gravely concerned that in recent times, pedigree medications which have traditionally been imported from places such as the US, UK, Germany, and other first world countries are now being replaced with alternative pharmaceuticals from manufacturers in places such as Central America which may cost more and not work as well.” End of quote. It is the belief of the Belize Community Pharmacist Association that changes to the Food and Drugs Regulations Act were made without proper consultations.